{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T14:01:38Z","timestamp":1789740098826,"version":"4.0.1"},"reference-count":179,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06216-w","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:01:58Z","timestamp":1789736518000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanisms of Selective Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive\u2013Compulsive Disorder: Cortico-Striatal Circuitry, Glutamatergic Dysregulation, and Neuroplastic Constraints"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1482-4411","authenticated-orcid":false,"given":"Abdullah Faisal","family":"Albukhari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"6216_CR1","doi-asserted-by":"publisher","unstructured":"Endres D, Schiele M, Von Zedtwitz K, Dressle R, Maier A, Hohagen F, Baldermann J, Coenen V et al (2025) Obsessive-compulsive disorder-a state-of-the-art review. Neuroscience Biobehavioral Rev 106320. https:\/\/doi.org\/10.1016\/j.neubiorev.2025.106320","DOI":"10.1016\/j.neubiorev.2025.106320"},{"issue":"1","key":"6216_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psc.2022.10.006","volume":"46","author":"M Cervin","year":"2022","unstructured":"Cervin M (2022) Obsessive-compulsive disorder: diagnosis, clinical features, nosology, and epidemiology. Psychiatr Clin North Am 46(1):1\u201316. https:\/\/doi.org\/10.1016\/j.psc.2022.10.006","journal-title":"Psychiatr Clin North Am"},{"key":"6216_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-04209-5","author":"D Stein","year":"2025","unstructured":"Stein D, Ruscio A, Altwaijri Y, Chiu W, Sampson N, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J et al (2025) Obsessive-compulsive disorder in the World Mental Health surveys. BMC Med. https:\/\/doi.org\/10.1186\/s12916-025-04209-5","journal-title":"BMC Med"},{"key":"6216_CR4","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1177\/0269881113495118","volume":"27","author":"N Fineberg","year":"2013","unstructured":"Fineberg N, Haddad P, Carpenter L, Gannon B, Sharpe R, Young A, Joyce E, Rowe J et al (2013) The size, burden and cost of disorders of the brain in the UK. J Psychopharmacol 27:761\u2013770. https:\/\/doi.org\/10.1177\/0269881113495118","journal-title":"J Psychopharmacol"},{"key":"6216_CR5","doi-asserted-by":"publisher","first-page":"710","DOI":"10.2174\/1570159x16666180813155017","volume":"17","author":"A Del Casale","year":"2019","unstructured":"Del Casale A, Sorice S, Padovano A, Simmaco M, Ferracuti S, Lamis D, Rapinesi C, Sani G et al (2019) Psychopharmacological treatment of obsessive-compulsive disorder (OCD). Curr Neuropharmacol 17:710\u2013736. https:\/\/doi.org\/10.2174\/1570159x16666180813155017","journal-title":"Curr Neuropharmacol"},{"key":"6216_CR6","doi-asserted-by":"publisher","unstructured":"Kotapati V, Khan A, Dar S, Begum G, Bachu R, Adnan M, Zubair A, Ahmed R (2019) The effectiveness of selective serotonin reuptake inhibitors for treatment of obsessive-compulsive disorder in adolescents and children: a systematic review and meta-analysis. Front Psychiatry 10. https:\/\/doi.org\/10.3389\/fpsyt.2019.00523","DOI":"10.3389\/fpsyt.2019.00523"},{"key":"6216_CR7","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/mp.2009.50","volume":"15","author":"M Bloch","year":"2010","unstructured":"Bloch M, McGuire J, Landeros-Weisenberger A, Leckman J, Pittenger C (2010) Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder. Mol Psychiatry 15:850\u2013855. https:\/\/doi.org\/10.1038\/mp.2009.50","journal-title":"Mol Psychiatry"},{"key":"6216_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4088\/jcp.19ac13182","volume":"81","author":"R Kayser","year":"2020","unstructured":"Kayser R (2020) Pharmacotherapy for treatment-resistant obsessive-compulsive disorder. J Clin Psychiatry 81:5. https:\/\/doi.org\/10.4088\/jcp.19ac13182","journal-title":"J Clin Psychiatry"},{"key":"6216_CR9","doi-asserted-by":"publisher","first-page":"152352","DOI":"10.1016\/j.comppsych.2022.152352","volume":"120","author":"P Van Roessel","year":"2022","unstructured":"Van Roessel P, Grassi G, Aboujaoude E, Mench\u00f3n J, Van Ameringen M, Rodriguez C (2022) Treatment-resistant OCD: pharmacotherapies in adults. Compr Psychiatry 120:152352. https:\/\/doi.org\/10.1016\/j.comppsych.2022.152352","journal-title":"Compr Psychiatry"},{"key":"6216_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14113858","author":"G Gualtieri","year":"2025","unstructured":"Gualtieri G, Cuomo A, Pardossi S, Fagiolini A (2025) When standard is not enough: a narrative review of supratherapeutic SSRI doses in resistant obsessive compulsive disorder. J Clin Med. https:\/\/doi.org\/10.3390\/jcm14113858","journal-title":"J Clin Med"},{"issue":"1","key":"6216_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1176\/appi.ajp.2020.20111601","volume":"178","author":"W Goodman","year":"2021","unstructured":"Goodman W, Storch E, Sheth S (2021) Harmonizing the neurobiology and treatment of obsessive-compulsive disorder. Am J Psychiatry 178(1):17\u201329. https:\/\/doi.org\/10.1176\/appi.ajp.2020.20111601","journal-title":"Am J Psychiatry"},{"key":"6216_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/7854_2020_204","author":"C Pittenger","year":"2021","unstructured":"Pittenger C (2021) Pharmacotherapeutic strategies and new targets in OCD. Curr Top Behav Neurosci. https:\/\/doi.org\/10.1007\/7854_2020_204","journal-title":"Curr Top Behav Neurosci"},{"key":"6216_CR13","doi-asserted-by":"publisher","unstructured":"De Oliveira M, De Barros P, De Mathis M, Boavista R, Chacon P, Echevarria M, Ferr\u00e3o Y, Vattimo E et al (2023) Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders guidelines for the treatment of adult obsessive-compulsive disorder. Part I: pharmacological treatment. Brazilian J Psychiatry 45:146\u2013161. https:\/\/doi.org\/10.47626\/1516-4446-2022-2891","DOI":"10.47626\/1516-4446-2022-2891"},{"key":"6216_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.tics.2011.11.003","volume":"16","author":"M Milad","year":"2012","unstructured":"Milad M, Rauch S (2012) Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways. Trends Cogn Sci 16:43\u201351. https:\/\/doi.org\/10.1016\/j.tics.2011.11.003","journal-title":"Trends Cogn Sci"},{"key":"6216_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.3000","author":"B Jalal","year":"2023","unstructured":"Jalal B, Chamberlain S, Sahakian B (2023) Obsessive\u2010compulsive disorder: etiology, neuropathology, and cognitive dysfunction. Brain Behav. https:\/\/doi.org\/10.1002\/brb3.3000","journal-title":"Brain Behav"},{"key":"6216_CR16","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/pcn.12683","volume":"72","author":"J Umemori","year":"2018","unstructured":"Umemori J, Winkel F, Didio G, Pou M, Castr\u00e9n E (2018) iPlasticity: induced juvenile-like plasticity in the adult brain as a mechanism of antidepressants. Psychiatry Clin Neurosci 72:633\u2013653. https:\/\/doi.org\/10.1111\/pcn.12683","journal-title":"Psychiatry Clin Neurosci"},{"key":"6216_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12122744","author":"G Rosas-S\u00e1nchez","year":"2024","unstructured":"Rosas-S\u00e1nchez G, Germ\u00e1n-Ponciano L, Guill\u00e9n-Ruiz G, Cueto-Escobedo J, Lim\u00f3n-V\u00e1zquez A, Rodr\u00edguez-Landa J, Soria-Fregozo C (2024) Neuroplasticity and mechanisms of action of acute and chronic treatment with antidepressants in preclinical studies. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines12122744","journal-title":"Biomedicines"},{"key":"6216_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2025.01.001","author":"S Cohen","year":"2025","unstructured":"Cohen S, De Boer A, Storosum B, Mattila T, Niemeijer M, Geller D, Denys D, Zantvoord J (2025) Systematic review and meta-analysis of individual participant data: randomized, placebo-controlled trials of selective serotonin reuptake inhibitors for pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. https:\/\/doi.org\/10.1016\/j.jaac.2025.01.001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"6216_CR19","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1192\/bjp.2025.87","volume":"227","author":"S Cohen","year":"2025","unstructured":"Cohen S, Storosum B, Zantvoord J, Mattila T, De Boer A, Denys D (2025) Individual patient data meta-analysis of placebo-controlled trials of selective serotonin reuptake inhibitors submitted for regulatory approval in adult obsessive\u2013compulsive disorder. Br J Psychiatry 227:680\u2013687. https:\/\/doi.org\/10.1192\/bjp.2025.87","journal-title":"Br J Psychiatry"},{"issue":"5","key":"6216_CR20","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1176\/appi.ajp.2020.20030280","volume":"177","author":"T Spellman","year":"2020","unstructured":"Spellman T, Liston C (2020) Toward circuit mechanisms of pathophysiology in depression. Am J Psychiatry 177(5):381\u2013390. https:\/\/doi.org\/10.1176\/appi.ajp.2020.20030280","journal-title":"Am J Psychiatry"},{"key":"6216_CR21","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41380-024-02780-6","volume":"30","author":"A Saberi","year":"2024","unstructured":"Saberi A, Ebneabbasi A, Rahimi S, Sarebannejad S, Sen Z, Graf H, Walter M, Sorg C et al (2024) Convergent functional effects of antidepressants in major depressive disorder: a neuroimaging meta-analysis. Mol Psychiatry 30:736\u2013751. https:\/\/doi.org\/10.1038\/s41380-024-02780-6","journal-title":"Mol Psychiatry"},{"key":"6216_CR22","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.conb.2011.04.010","volume":"21","author":"J Ting","year":"2011","unstructured":"Ting J, Feng G (2011) Neurobiology of obsessive\u2013compulsive disorder: insights into neural circuitry dysfunction through mouse genetics. Curr Opin Neurobiol 21:842\u2013848. https:\/\/doi.org\/10.1016\/j.conb.2011.04.010","journal-title":"Curr Opin Neurobiol"},{"key":"6216_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00319","author":"J Calz\u00e0","year":"2019","unstructured":"Calz\u00e0 J, G\u00fcrsel D, Schmitz-Koep B, Bremer B, Reinholz L, Berberich G, Koch K (2019) Altered cortico\u2013striatal functional connectivity during resting state in obsessive\u2013compulsive disorder. Front Psychiatry. https:\/\/doi.org\/10.3389\/fpsyt.2019.00319","journal-title":"Front Psychiatry"},{"key":"6216_CR24","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.4103\/psychiatry.indianjpsychiatry_525_18","volume":"61","author":"N Hazari","year":"2019","unstructured":"Hazari N, Narayanaswamy J, Venkatasubramanian G (2019) Neuroimaging findings in obsessive\u2013compulsive disorder: a narrative review to elucidate neurobiological underpinnings. Indian J Psychiatry 61:S9\u2013S29. https:\/\/doi.org\/10.4103\/psychiatry.indianjpsychiatry_525_18","journal-title":"Indian J Psychiatry"},{"issue":"1","key":"6216_CR25","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00406-023-01594-x","volume":"274","author":"Z Yang","year":"2024","unstructured":"Yang Z,\u00a0Xiao S, Su T, Gong J, Qi Z, Chen G, Chen P, Tang G\u00a0et al (2024) A multimodal meta-analysis of regional functional and structural brain abnormalities in obsessive\u2013compulsive disorder. Eur Arch Psychiatry Clin Neurosci 274(1):165\u2013180","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"9","key":"6216_CR26","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.biopsych.2018.11.010","volume":"85","author":"LJ Norman","year":"2019","unstructured":"Norman LJ,\u00a0Taylor SF, Liu Y, Radua J, Chye Y, De Wit SJ, Huyser C, Karahanoglu FI et al (2019) Error processing and inhibitory control in obsessive-compulsive disorder: a meta-analysis using statistical parametric maps. Biol Psychiatry 85(9):713\u2013725","journal-title":"Biol Psychiatry"},{"key":"6216_CR27","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1126\/science.1234733","volume":"340","author":"S Ahmari","year":"2013","unstructured":"Ahmari S, Spellman T, Douglass N, Kheirbek M, Simpson H, Deisseroth K, Gordon J, Hen R (2013) Repeated cortico-striatal stimulation generates persistent OCD-like behavior. Science 340:1234\u20131239. https:\/\/doi.org\/10.1126\/science.1234733","journal-title":"Science"},{"key":"6216_CR28","doi-asserted-by":"publisher","unstructured":"Liu J, Cao L, Li H, Gao Y, Bu X, Liang K, Bao W, Zhang S et al (2022) Abnormal resting-state functional connectivity in patients with obsessive-compulsive disorder: a systematic review and meta-analysis. Neuroscience Biobehavioral Rev 135. https:\/\/doi.org\/10.1016\/j.neubiorev.2022.104574","DOI":"10.1016\/j.neubiorev.2022.104574"},{"key":"6216_CR29","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1212\/wnl.0000000000004680","volume":"89","author":"J Graff-Radford","year":"2017","unstructured":"Graff-Radford J, Williams L, Jones D, Benarroch E (2017) Caudate nucleus as a component of networks controlling behavior. Neurology 89:2192\u20132197. https:\/\/doi.org\/10.1212\/wnl.0000000000004680","journal-title":"Neurology"},{"key":"6216_CR30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.neuron.2017.09.019","volume":"96","author":"D Burke","year":"2017","unstructured":"Burke D, Rotstein H, Alvarez V (2017) Striatal local circuitry: a new framework for lateral inhibition. Neuron 96:267\u2013284. https:\/\/doi.org\/10.1016\/j.neuron.2017.09.019","journal-title":"Neuron"},{"key":"6216_CR31","doi-asserted-by":"publisher","unstructured":"Nyl\u00e9n J, Hjorth J, Kozlov A, Carannante I, Kotaleski J, Grillner S (2023) The roles of surround inhibition for the intrinsic function of the striatum, analyzed in silico. Proceedings of the National Academy of Sciences of the United States of America, p 120. https:\/\/doi.org\/10.1073\/pnas.2313058120","DOI":"10.1073\/pnas.2313058120"},{"key":"6216_CR32","doi-asserted-by":"publisher","unstructured":"Poli A, Pozza A, Orr\u00fa G, Conversano C, Ciacchini R, Pugi D, Angelo N, Angeletti L et al (2022) Neurobiological outcomes of cognitive behavioral therapy for obsessive-compulsive disorder: a systematic review. Front Psychiatry 13. https:\/\/doi.org\/10.3389\/fpsyt.2022.1063116","DOI":"10.3389\/fpsyt.2022.1063116"},{"issue":"5","key":"6216_CR33","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00406-024-01852-6","volume":"275","author":"C Stephenson","year":"2025","unstructured":"Stephenson C, Philipp-Muller A, Moghimi E, Nashed JY, Cook DJ, Shirazi A, Milev R, Alavi N (2025) Effects of cognitive behavioural therapy and exposure\u2013response prevention on brain activation in obsessive\u2013compulsive disorder patients: systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci 275(5):1491\u20131507","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"1","key":"6216_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1176\/appi.ajp.2020.20111601","volume":"178","author":"WK Goodman","year":"2021","unstructured":"Goodman WK, Storch EA, Sheth SA (2021) Harmonizing the neurobiology and treatment of obsessive-compulsive disorder. Am J Psychiatry 178(1):17\u201329","journal-title":"Am J Psychiatry"},{"key":"6216_CR35","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.pbb.2011.10.007","volume":"100","author":"K Wu","year":"2012","unstructured":"Wu K, Hanna G, Rosenberg D, Arnold P (2012) The role of glutamate signaling in the pathogenesis and treatment of obsessive\u2013compulsive disorder. Pharmacol Biochem Behav 100:726\u2013735. https:\/\/doi.org\/10.1016\/j.pbb.2011.10.007","journal-title":"Pharmacol Biochem Behav"},{"key":"6216_CR36","doi-asserted-by":"publisher","first-page":"568","DOI":"10.5498\/wjp.v11.i9.568","volume":"11","author":"A Maraone","year":"2021","unstructured":"Maraone A, Tarsitani L, Pinucci I, Pasquini M (2021) Antiglutamatergic agents for obsessive-compulsive disorder: where are we now and what are possible future prospects? World J Psychiatry 11:568\u2013580. https:\/\/doi.org\/10.5498\/wjp.v11.i9.568","journal-title":"World J Psychiatry"},{"key":"6216_CR37","doi-asserted-by":"publisher","unstructured":"Bijanki K, Pathak Y, Najera R, Storch E, Goodman W, Simpson H, Sheth S, iD O (2021) Defining functional brain networks underlying obsessive\u2013compulsive disorder (OCD) using treatment-induced neuroimaging changes: a systematic review of the literature. J Neurol Neurosurgery Psychiatry 92:776\u2013786. https:\/\/doi.org\/10.1136\/jnnp-2020-324478","DOI":"10.1136\/jnnp-2020-324478"},{"key":"6216_CR38","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1038\/npp.2016.260","volume":"42","author":"J Naaijen","year":"2017","unstructured":"Naaijen J, Zwiers M, Amiri H, Williams S, Durston S, Oranje B, Brandeis D, Boecker-Schlier R et al (2017) Fronto-striatal glutamate in autism spectrum disorder and obsessive compulsive disorder. Neuropsychopharmacology 42:2456\u20132465. https:\/\/doi.org\/10.1038\/npp.2016.260","journal-title":"Neuropsychopharmacology"},{"key":"6216_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38695-z","author":"M Biria","year":"2023","unstructured":"Biria M, Banca P, Healy M, Keser E, Sawiak S, Rodgers C, Rua C, De Souza A et al (2023) Cortical glutamate and GABA are related to compulsive behaviour in individuals with obsessive compulsive disorder and healthy controls. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-023-38695-z","journal-title":"Nat Commun"},{"issue":"7","key":"6216_CR40","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/pcn.12850","volume":"73","author":"A Parmar","year":"2019","unstructured":"Parmar A et al (2019) Brain neurochemistry in unmedicated obsessive\u2013compulsive disorder patients and effects of 12-week escitalopram treatment: 1H-magnetic resonance spectroscopy study. Psychiatry Clin Neurosci 73(7):386\u2013393","journal-title":"Psychiatry Clin Neurosci"},{"key":"6216_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.668304","author":"M Batistuzzo","year":"2021","unstructured":"Batistuzzo M, Sottili B, Shavitt R, Lopes A, Cappi C, De Mathis M, Pastorello B, Diniz J et al (2021) Lower ventromedial prefrontal cortex glutamate levels in patients with obsessive\u2013compulsive disorder. Front Psychiatry. https:\/\/doi.org\/10.3389\/fpsyt.2021.668304","journal-title":"Front Psychiatry"},{"key":"6216_CR42","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41386-021-01207-y","volume":"47","author":"A Casado-Sainz","year":"2021","unstructured":"Casado-Sainz A, Gudmundsen F, Baerentzen S, Lange D, Ringsted A, Martinez-Tejada I, Medina S, Lee H et al (2021) Dorsal striatal dopamine induces fronto-cortical hypoactivity and attenuates anxiety and compulsive behaviors in rats. Neuropsychopharmacology 47:454\u2013464. https:\/\/doi.org\/10.1038\/s41386-021-01207-y","journal-title":"Neuropsychopharmacology"},{"key":"6216_CR43","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s11571-022-09858-3","volume":"17","author":"L Yin","year":"2022","unstructured":"Yin L, Han F, Yu Y, Wang Q (2022) A computational network dynamical modeling for abnormal oscillation and deep brain stimulation control of obsessive\u2013compulsive disorder. Cogn Neurodyn 17:1167\u20131184. https:\/\/doi.org\/10.1007\/s11571-022-09858-3","journal-title":"Cogn Neurodyn"},{"key":"6216_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jpsychires.2025.12.007","volume":"194","author":"P Mota","year":"2025","unstructured":"Mota P, Pic\u00f3-P\u00e9rez M, Morgado P (2025) Mapping dopamine\u2019s role in obsessive-compulsive disorder: a scoping review of neural circuits, brain regions, and behavioral implications. J Psychiatr Res 194:11\u201320. https:\/\/doi.org\/10.1016\/j.jpsychires.2025.12.007","journal-title":"J Psychiatr Res"},{"key":"6216_CR45","doi-asserted-by":"publisher","unstructured":"Dold M, Aigner M, Lanzenberger R, Kasper S (2013) Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: an update meta-analysis of double-blind, randomized, placebo-controlled trials. Int J Neuropsychopharmacology 18. https:\/\/doi.org\/10.1093\/ijnp\/pyv047","DOI":"10.1093\/ijnp\/pyv047"},{"key":"6216_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2019.00077","author":"M Mele","year":"2019","unstructured":"Mele M, Costa R, Duarte C (2019) Alterations in GABAA-receptor trafficking and synaptic dysfunction in brain disorders. Front Cell Neurosci. https:\/\/doi.org\/10.3389\/fncel.2019.00077","journal-title":"Front Cell Neurosci"},{"key":"6216_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23147965","author":"E Bolneo","year":"2022","unstructured":"Bolneo E, Chau P, Noakes P, Bellingham M (2022) Investigating the role of GABA in neural development and disease using mice lacking GAD67 or VGAT genes. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23147965","journal-title":"Int J Mol Sci"},{"key":"6216_CR48","doi-asserted-by":"publisher","unstructured":"Zhang Z, Fan Q, Bai Y, Wang Z, Zhang H Xiao Z-P (2016) Brain Gamma-Aminobutyric Acid (GABA) concentration of the prefrontal lobe in unmedicated patients with obsessive-compulsive disorder: a research of magnetic resonance spectroscopy. Shanghai Archives Psychiatry 28(5):263\u2013270. https:\/\/doi.org\/10.11919\/j.issn.1002-0829.216043","DOI":"10.11919\/j.issn.1002-0829.216043"},{"key":"6216_CR49","doi-asserted-by":"publisher","first-page":"100523","DOI":"10.1016\/j.jocrd.2020.100523","volume":"25","author":"EL Vester","year":"2020","unstructured":"Vester EL, Joode ND, Vriend C, Pouwels P, Heuvel OVD (2020) Little evidence for neurometabolite alterations in obsessive-compulsive disorder - a systematic review of magnetic resonance spectroscopy studies at 3 Tesla. J Obsessive-Compulsive Related Disorders 25:100523. https:\/\/doi.org\/10.1016\/j.jocrd.2020.100523","journal-title":"J Obsessive-Compulsive Related Disorders"},{"key":"6216_CR50","doi-asserted-by":"publisher","unstructured":"Vellucci L, Ciccarelli M, Buonaguro E, Fornaro M, D\u2019Urso G, De Simone G, Iasevoli F, Barone A et al (2023) The neurobiological underpinnings of obsessive-compulsive symptoms in psychosis, translational issues for treatment-resistant schizophrenia. Biomolecules 13. https:\/\/doi.org\/10.3390\/biom13081220","DOI":"10.3390\/biom13081220"},{"key":"6216_CR51","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1038\/s41380-024-02625-2","volume":"29","author":"C Page","year":"2024","unstructured":"Page C, Epperson C, Novick A, Duffy K, Thompson S (2024) Beyond the serotonin deficit hypothesis: communicating a neuroplasticity framework of major depressive disorder. Mol Psychiatry 29:3802\u20133813. https:\/\/doi.org\/10.1038\/s41380-024-02625-2","journal-title":"Mol Psychiatry"},{"key":"6216_CR52","doi-asserted-by":"publisher","unstructured":"James G, Baldinger-Melich P, Philippe C, Kranz G, Vanicek T, Hahn A, Gryglewski G, Hienert M et al (2017) Effects of selective serotonin reuptake inhibitors on interregional relation of serotonin transporter availability in major depression. Front Human Neurosci 11. https:\/\/doi.org\/10.3389\/fnhum.2017.00048","DOI":"10.3389\/fnhum.2017.00048"},{"key":"6216_CR53","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1177\/02698811231211154","volume":"37","author":"D Boucherie","year":"2023","unstructured":"Boucherie D, Reneman L, Booij J, Martins D, Dipasquale O, Schrantee A (2023) Modulation of functional networks related to the serotonin neurotransmitter system by citalopram: evidence from a multimodal neuroimaging study. J Psychopharmacol 37:1209\u20131217. https:\/\/doi.org\/10.1177\/02698811231211154","journal-title":"J Psychopharmacol"},{"key":"6216_CR54","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/mp.2011.159","volume":"17","author":"S Diaz","year":"2012","unstructured":"Diaz S, Doly S, Doly S, Narboux-N\u00eame N, Narboux-N\u00eame N, Fernandez S, Fernandez S, Mazot P et al (2012) 5-HT2B receptors are required for serotonin-selective antidepressant actions. Mol Psychiatry 17:154\u2013163. https:\/\/doi.org\/10.1038\/mp.2011.159","journal-title":"Mol Psychiatry"},{"key":"6216_CR55","unstructured":"Szoke-Kovacs Z, M\u00f3r\u00e9 C, Szoke-Kovacs R, M\u00e1th\u00e9 E, Frecska E (2020) Selective inhibition of the serotonin transporter in the treatment of depression: sertraline, fluoxetine and citalopram.. Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official J Hungarian Association Psychopharmacol 22(1):4\u201315"},{"key":"6216_CR56","doi-asserted-by":"publisher","unstructured":"Celada P, Puig V, Artigas F, Wong-Lin K, Romcy-Pereira R, Gruber A (2013) Serotonin modulation of cortical neurons and networks. Front Integrative Neurosci 7. https:\/\/doi.org\/10.3389\/fnint.2013.00025","DOI":"10.3389\/fnint.2013.00025"},{"key":"6216_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2024.110036","author":"G Higa","year":"2024","unstructured":"Higa G, Viana F, Francis-Oliveira J, Cruvinel E, Franchin T, Marcourakis T, Ulrich H, De Pasquale R (2024) Serotonergic neuromodulation of synaptic plasticity. Neuropharmacology. https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110036","journal-title":"Neuropharmacology"},{"issue":"7","key":"6216_CR58","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1021\/cn500340j","volume":"6","author":"S Leiser","year":"2015","unstructured":"Leiser S, Li Y, Pehrson A, Dale E, Smagin G, S\u00e1nchez C (2015) Serotonergic regulation of prefrontal cortical circuitries involved in cognitive processing: a review of individual 5-HT receptor mechanisms and concerted effects of 5-HT receptors exemplified by the multimodal antidepressant vortioxetine. ACS Chem Neurosci 6(7):970\u2013986. https:\/\/doi.org\/10.1021\/cn500340j","journal-title":"ACS Chem Neurosci"},{"key":"6216_CR59","doi-asserted-by":"publisher","first-page":"6766","DOI":"10.1523\/jneurosci.22-15-06766.2002","volume":"22","author":"S Benmansour","year":"2002","unstructured":"Benmansour S, Owens W, Cecchi M, Morilak D, Frazer A (2002) Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter. J Neurosci 22:6766\u20136772. https:\/\/doi.org\/10.1523\/jneurosci.22-15-06766.2002","journal-title":"J Neurosci"},{"key":"6216_CR60","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/s0006-3223(98)00114-0","volume":"44","author":"P Blier","year":"1998","unstructured":"Blier P, Montigny C (1998) Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive\u2013compulsive disorder responses. Biol Psychiatry 44:313\u2013323. https:\/\/doi.org\/10.1016\/s0006-3223(98)00114-0","journal-title":"Biol Psychiatry"},{"key":"6216_CR61","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.pnpbp.2005.11.005","volume":"30","author":"M Mansari","year":"2006","unstructured":"Mansari M, Blier P (2006) Mechanisms of action of current and potential pharmacotherapies of obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 30:362\u2013373. https:\/\/doi.org\/10.1016\/j.pnpbp.2005.11.005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"6216_CR62","doi-asserted-by":"publisher","unstructured":"Fritze S, Spanagel R, Noori H (2017) Adaptive dynamics of the 5\u2010HT systems following chronic administration of selective serotonin reuptake inhibitors: a meta\u2010analysis. J Neurochemistry 142. https:\/\/doi.org\/10.1111\/jnc.14114","DOI":"10.1111\/jnc.14114"},{"key":"6216_CR63","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/jnc.13528","volume":"136","author":"E Dankoski","year":"2016","unstructured":"Dankoski E, Carroll S, Wightman R (2016) Acute selective serotonin reuptake inhibitors regulate the dorsal raphe nucleus causing amplification of terminal serotonin release. J Neurochem 136:1131\u20131141. https:\/\/doi.org\/10.1111\/jnc.13528","journal-title":"J Neurochem"},{"key":"6216_CR64","doi-asserted-by":"publisher","first-page":"4272","DOI":"10.1038\/s41380-023-02285-8","volume":"28","author":"A Johansen","year":"2023","unstructured":"Johansen A, Armand S, Plav\u00e9n-Sigray P, Nasser A, Ozenne B, Petersen I, Keller S, Madsen J et al (2023) Effects of escitalopram on synaptic density in the healthy human brain: a randomized controlled trial. Mol Psychiatry 28:4272\u20134279. https:\/\/doi.org\/10.1038\/s41380-023-02285-8","journal-title":"Mol Psychiatry"},{"key":"6216_CR65","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neuropharm.2015.10.034","volume":"102","author":"C Bj\u00f6rkholm","year":"2016","unstructured":"Bj\u00f6rkholm C, Monteggia L (2016) BDNF \u2013 a key transducer of antidepressant effects. Neuropharmacology 102:72\u201379. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.10.034","journal-title":"Neuropharmacology"},{"key":"6216_CR66","doi-asserted-by":"publisher","unstructured":"Lissemore J, Sookman D, Gravel P, Berney A, Barsoum A, Diksic M, Nordahl T, Pinard G et al (2018) Brain serotonin synthesis capacity in obsessive-compulsive disorder: effects of cognitive behavioral therapy and sertraline. Translational Psychiatry 8. https:\/\/doi.org\/10.1038\/s41398-018-0128-4","DOI":"10.1038\/s41398-018-0128-4"},{"key":"6216_CR67","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bbr.2016.07.004","volume":"313","author":"W Tang","year":"2016","unstructured":"Tang W, Zhu Q, Gong X, Zhu C, Wang Y, Chen S (2016) Cortico-striato-thalamo-cortical circuit abnormalities in obsessive-compulsive disorder: a voxel-based morphometric and fMRI study of the whole brain. Behav Brain Res 313:17\u201322. https:\/\/doi.org\/10.1016\/j.bbr.2016.07.004","journal-title":"Behav Brain Res"},{"key":"6216_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2023.10.034","author":"L Bracco","year":"2023","unstructured":"Bracco L, Dusi N, Moltrasio C, Brambilla P, Delvecchio G (2023) Structural and functional brain imaging after treatment with selective-serotonin reuptake-inhibitors in obsessive-compulsive disorder: a mini review. J Affect Disord. https:\/\/doi.org\/10.1016\/j.jad.2023.10.034","journal-title":"J Affect Disord"},{"key":"6216_CR69","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.biopsych.2013.09.002","volume":"75","author":"D Shin","year":"2014","unstructured":"Shin D, Jung W, He Y, Wang J, Kwon J (2014) The effects of pharmacological treatment on functional brain connectome in obsessive-compulsive disorder. Biol Psychiatry 75:606\u2013614. https:\/\/doi.org\/10.1016\/j.biopsych.2013.09.002","journal-title":"Biol Psychiatry"},{"key":"6216_CR70","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/pcn.13760","volume":"79","author":"M Pastre","year":"2024","unstructured":"Pastre M, Occean B, Boudousq V, Conejero I, Fabbro-Peray P, Collombier L, Mallet L, L\u00f3pez-Castroman J (2024) Serotonergic underpinnings of obsessive-compulsive disorder: a systematic review and meta-analysis of neuroimaging findings. Psychiatry Clin Neurosci 79:48\u201359. https:\/\/doi.org\/10.1111\/pcn.13760","journal-title":"Psychiatry Clin Neurosci"},{"issue":"3","key":"6216_CR71","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.pharmthera.2011.09.006","volume":"132","author":"C Pittenger","year":"2011","unstructured":"Pittenger C, Bloch M, Williams K (2011) Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment. Pharmacol Ther 132(3):314\u2013332. https:\/\/doi.org\/10.1016\/j.pharmthera.2011.09.006","journal-title":"Pharmacol Ther"},{"key":"6216_CR72","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1055\/s-0043-118665","volume":"51","author":"P Vl\u010dek","year":"2017","unstructured":"Vl\u010dek P, Pol\u00e1k J, Brunovsk\u00fd M, Hor\u00e1\u010dek J (2017) Role of glutamatergic system in obsessive-compulsive disorder with possible therapeutic implications. Pharmacopsychiatry 51:229\u2013242. https:\/\/doi.org\/10.1055\/s-0043-118665","journal-title":"Pharmacopsychiatry"},{"key":"6216_CR73","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neubiorev.2015.02.009","volume":"52","author":"J Naaijen","year":"2015","unstructured":"Naaijen J, Lythgoe D, Amiri H, Buitelaar J, Glennon J (2015) Fronto-striatal glutamatergic compounds in compulsive and impulsive syndromes: a review of magnetic resonance spectroscopy studies. Neurosci Biobehav Rev 52:74\u201388. https:\/\/doi.org\/10.1016\/j.neubiorev.2015.02.009","journal-title":"Neurosci Biobehav Rev"},{"key":"6216_CR74","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1038\/npp.2012.132","volume":"37","author":"H Simpson","year":"2012","unstructured":"Simpson H, Shungu D, Bender J, Mao X, Xu X, Slifstein M, Kegeles L (2012) Investigation of cortical glutamate\u2013glutamine and \u03b3-aminobutyric acid in obsessive\u2013compulsive disorder by proton magnetic resonance spectroscopy. Neuropsychopharmacology 37:2684\u20132692. https:\/\/doi.org\/10.1038\/npp.2012.132","journal-title":"Neuropsychopharmacology"},{"key":"6216_CR75","doi-asserted-by":"publisher","unstructured":"Li Y, Zhang C, Weidacker K, Zhang Y, He N, Jin H-Y, Chen W, Voon V et al (2019) Investigation of anterior cingulate cortex gamma-aminobutyric acid and glutamate-glutamine levels in obsessive-compulsive disorder using magnetic resonance spectroscopy. BMC Psychiatry 19. https:\/\/doi.org\/10.1186\/s12888-019-2160-1","DOI":"10.1186\/s12888-019-2160-1"},{"issue":"7","key":"6216_CR76","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1001\/archpsyc.63.7.769","volume":"63","author":"PD Arnold","year":"2006","unstructured":"Arnold PD, Sicard T, Burroughs E, Richter MA, Kennedy JL (2006) Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Arch Gen Psychiatry 63(7):769\u2013776. https:\/\/doi.org\/10.1001\/archpsyc.63.7.769","journal-title":"Arch Gen Psychiatry"},{"issue":"7","key":"6216_CR77","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1001\/archpsyc.63.7.778","volume":"63","author":"DE Dickel","year":"2006","unstructured":"Dickel DE, Veenstra-VanderWeele J, Cox NJ, Wu X, Fischer DJ, Van Etten-Lee M, Himle JA, Leventhal BL et al (2006) Association testing of the positional and functional candidate gene SLC1A1\/EAAC1 in early-onset obsessive-compulsive disorder. Arch Gen Psychiatry 63(7):778\u2013785. https:\/\/doi.org\/10.1001\/archpsyc.63.7.778","journal-title":"Arch Gen Psychiatry"},{"key":"6216_CR78","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.bpsgos.2021.11.009","volume":"2","author":"M Su\u00f1ol","year":"2021","unstructured":"Su\u00f1ol M, Alemany S, Bustamante M, D\u00edez I, Contreras-Rodr\u00edguez O, Laudo B, Maci\u00e0 D, Mart\u00ednez-Vilavella G et al (2021) Neurogenetics of dynamic connectivity patterns associated with obsessive-compulsive symptoms in healthy children. Biol Psychiatry Glob Open Sci 2:411\u2013420. https:\/\/doi.org\/10.1016\/j.bpsgos.2021.11.009","journal-title":"Biol Psychiatry Glob Open Sci"},{"key":"6216_CR79","doi-asserted-by":"publisher","unstructured":"Xie G, Zuo W, Wu L, Li W, Wu W, Bekker A, Ye J (2016) Serotonin modulates glutamatergic transmission to neurons in the lateral habenula. Scientific Rep 6. https:\/\/doi.org\/10.1038\/srep23798","DOI":"10.1038\/srep23798"},{"key":"6216_CR80","doi-asserted-by":"publisher","first-page":"4572","DOI":"10.1093\/cercor\/bhv098","volume":"25","author":"C B\u00f6hm","year":"2015","unstructured":"B\u00f6hm C, Pangalos M, Schmitz D, Winterer J (2015) Serotonin attenuates feedback excitation onto O-LM interneurons. Cerebral cortex (New York, NY\u202f: 1991) 25:4572\u20134583. https:\/\/doi.org\/10.1093\/cercor\/bhv098","journal-title":"Cerebral cortex (New York, NY : 1991)"},{"key":"6216_CR81","doi-asserted-by":"publisher","first-page":"117913","DOI":"10.1016\/j.neuroimage.2021.117913","volume":"232","author":"B Spurny","year":"2021","unstructured":"Spurny B, Vanicek T, Seiger R, Reed M, Kl\u00f6bl M, Ritter V, Unterholzner J, Godbersen G et al (2021) Effects of SSRI treatment on GABA and glutamate levels in an associative relearning paradigm. Neuroimage 232:117913\u2013117913. https:\/\/doi.org\/10.1016\/j.neuroimage.2021.117913","journal-title":"Neuroimage"},{"key":"6216_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108926","author":"H Hatakama","year":"2021","unstructured":"Hatakama H, Asaoka N, Nagayasu K, Shirakawa H, Kaneko S (2021) A selective serotonin reuptake inhibitor ameliorates obsessive\u2013compulsive disorder-like perseverative behavior by attenuating 5-HT2C receptor signaling in the orbitofrontal cortex. Neuropharmacology. https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108926","journal-title":"Neuropharmacology"},{"key":"6216_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.brs.2024.04.001","author":"L Melo","year":"2024","unstructured":"Melo L, Beaupain MC, Ghanavati E, Kuo M, Nitsche M (2024) Neurochemical mechanisms underlying serotonergic modulation of neuroplasticity in humans. Brain Stimul. https:\/\/doi.org\/10.1016\/j.brs.2024.04.001","journal-title":"Brain Stimul"},{"key":"6216_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41537-017-0037-1","author":"S O\u2019Donovan","year":"2017","unstructured":"O\u2019Donovan S, Sullivan C, Mccullumsmith R (2017) The role of glutamate transporters in the pathophysiology of neuropsychiatric disorders. NPJ Schizophr. https:\/\/doi.org\/10.1038\/s41537-017-0037-1","journal-title":"NPJ Schizophr"},{"key":"6216_CR85","doi-asserted-by":"publisher","unstructured":"Hadi F, Kashefinejad S, Kamalzadeh L, Hoobehfekr S, Shalbafan M (2021) Glutamatergic medications as adjunctive therapy for moderate to severe obsessive-compulsive disorder in adults: a systematic review and meta-analysis. BMC Pharmacol Toxicol 22. https:\/\/doi.org\/10.1186\/s40360-021-00534-6","DOI":"10.1186\/s40360-021-00534-6"},{"key":"6216_CR86","doi-asserted-by":"publisher","unstructured":"Coelho D, Yang C, Suriaga A, Manasa J, Bain P, Vieira W, Papatheodorou S, Salvi J (2025) Glutamatergic medications for obsessive-compulsive and related disorders. JAMA Network Open, p 8. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.52963","DOI":"10.1001\/jamanetworkopen.2024.52963"},{"key":"6216_CR87","doi-asserted-by":"publisher","first-page":"977","DOI":"10.2174\/1570159x15666170320104237","volume":"15","author":"Z Marinova","year":"2017","unstructured":"Marinova Z, Chuang D, Fineberg N (2017) Glutamate-modulating drugs as a potential therapeutic strategy in obsessive-compulsive disorder. Curr Neuropharmacol 15:977\u2013995. https:\/\/doi.org\/10.2174\/1570159x15666170320104237","journal-title":"Curr Neuropharmacol"},{"key":"6216_CR88","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40501-015-0051-8","volume":"2","author":"C Pittenger","year":"2015","unstructured":"Pittenger C (2015) Glutamatergic agents for OCD and related disorders. Curr Treat Options Psychiatry 2:271\u2013283. https:\/\/doi.org\/10.1007\/s40501-015-0051-8","journal-title":"Curr Treat Options Psychiatry"},{"key":"6216_CR89","doi-asserted-by":"publisher","unstructured":"Nicosia N, Giovenzana M, Misztak P, Mingardi J, Musazzi L (2024) Glutamate-mediated excitotoxicity in the pathogenesis and treatment of neurodevelopmental and adult mental disorders. Int J Molecular Sci 25. https:\/\/doi.org\/10.3390\/ijms25126521","DOI":"10.3390\/ijms25126521"},{"key":"6216_CR90","doi-asserted-by":"publisher","first-page":"737","DOI":"10.2174\/1570159x16666180613074059","volume":"17","author":"M Atmaca","year":"2019","unstructured":"Atmaca M (2019) Functional and structural neural changes in obsessive-compulsive disorder after pharmacotherapy. Curr Neuropharmacol 17:737\u2013740. https:\/\/doi.org\/10.2174\/1570159x16666180613074059","journal-title":"Curr Neuropharmacol"},{"key":"6216_CR91","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/mp.2017.61","volume":"22","author":"E Castr\u00e9n","year":"2017","unstructured":"Castr\u00e9n E, Antila H (2017) Neuronal plasticity and neurotrophic factors in drug responses. Mol Psychiatry 22:1085\u20131095. https:\/\/doi.org\/10.1038\/mp.2017.61","journal-title":"Mol Psychiatry"},{"key":"6216_CR92","doi-asserted-by":"publisher","unstructured":"Gonzalez L, Bezzi P (2025) Astrocyte dysfunctions in obsessive compulsive disorder: rethinking neurobiology and therapeutic targets. J Neurochemistry 169. https:\/\/doi.org\/10.1111\/jnc.70092","DOI":"10.1111\/jnc.70092"},{"key":"6216_CR93","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1038\/s41380-025-03013-0","volume":"30","author":"Z Shi","year":"2025","unstructured":"Shi Z, Wen K, Sammudin N, LoRocco N, Zhuang X (2025) Erasing \u201cbad memories\u201d: reversing aberrant synaptic plasticity as therapy for neurological and psychiatric disorders. Mol Psychiatry 30:3209\u20133225. https:\/\/doi.org\/10.1038\/s41380-025-03013-0","journal-title":"Mol Psychiatry"},{"key":"6216_CR94","doi-asserted-by":"publisher","first-page":"6159","DOI":"10.1038\/s41380-021-01235-6","volume":"26","author":"A Kruyer","year":"2021","unstructured":"Kruyer A, Parrilla-Carrero J, Powell C, Brandt L, Gutwinski S, Angelis A, Chalhoub R, Jhou T et al (2021) Accumbens D2-MSN hyperactivity drives antipsychotic-induced behavioral supersensitivity. Mol Psychiatry 26:6159\u20136169. https:\/\/doi.org\/10.1038\/s41380-021-01235-6","journal-title":"Mol Psychiatry"},{"key":"6216_CR95","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.jpsychires.2022.05.026","volume":"151","author":"L Hao","year":"2022","unstructured":"Hao L, Du Y, Chen L, Jiao Y, Cheng Y (2022) Brain-derived neurotrophic factor as a biomarker for obsessive-compulsive disorder: a meta-analysis. J Psychiatr Res 151:676\u2013682. https:\/\/doi.org\/10.1016\/j.jpsychires.2022.05.026","journal-title":"J Psychiatr Res"},{"key":"6216_CR96","doi-asserted-by":"publisher","unstructured":"Oliveira-Maia A, Castro-Rodrigues P (2015) Brain-derived neurotrophic factor: a biomarker for obsessive-compulsive disorder?. Front Neurosci 9. https:\/\/doi.org\/10.3389\/fnins.2015.00134","DOI":"10.3389\/fnins.2015.00134"},{"key":"6216_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158417","author":"A Bazzari","year":"2022","unstructured":"Bazzari A, Bazzari F (2022) BDNF therapeutic mechanisms in neuropsychiatric disorders. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23158417","journal-title":"Int J Mol Sci"},{"key":"6216_CR98","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.neubiorev.2018.01.016","volume":"87","author":"D G\u00fcrsel","year":"2018","unstructured":"G\u00fcrsel D, Avram M, Sorg C, Brandl F, Koch K (2018) Frontoparietal areas link impairments of large-scale intrinsic brain networks with aberrant fronto-striatal interactions in OCD: a meta-analysis of resting-state functional connectivity. Neurosci Biobehav Rev 87:151\u2013160. https:\/\/doi.org\/10.1016\/j.neubiorev.2018.01.016","journal-title":"Neurosci Biobehav Rev"},{"key":"6216_CR99","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1038\/npp.2015.292","volume":"41","author":"K Dunlop","year":"2015","unstructured":"Dunlop K, Woodside B, Olmsted M, Colton P, Giacobbe P, Downar J (2015) Reductions in cortico-striatal hyperconnectivity accompany successful treatment of obsessive-compulsive disorder with dorsomedial prefrontal rTMS. Neuropsychopharmacology 41:1395\u20131403. https:\/\/doi.org\/10.1038\/npp.2015.292","journal-title":"Neuropsychopharmacology"},{"key":"6216_CR100","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","volume":"23","author":"C Ly","year":"2018","unstructured":"Ly C, Greb A, Cameron L, Wong J, Barragan E, Wilson P, Burbach K, Zarandi S et al (2018) Psychedelics promote structural and functional neural plasticity. Cell Rep 23:3170\u20133182. https:\/\/doi.org\/10.1016\/j.celrep.2018.05.022","journal-title":"Cell Rep"},{"key":"6216_CR101","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1126\/science.adf0435","volume":"379","author":"M Vargas","year":"2023","unstructured":"Vargas M, Dunlap L, Dong C, Carter S, Tombari R, Jami S, Cameron L, Patel S et al (2023) Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors. Science 379:700\u2013706. https:\/\/doi.org\/10.1126\/science.adf0435","journal-title":"Science"},{"issue":"10","key":"6216_CR102","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1017\/s1461145709000376","volume":"12","author":"D Tardito","year":"2009","unstructured":"Tardito D, Musazzi L, Tiraboschi E, Mallei A, Racagni G, Popoli M (2009) Early induction of CREB activation and CREB-regulating signalling by antidepressants. Int J Neuropsychopharmacol 12(10):1367\u20131381. https:\/\/doi.org\/10.1017\/s1461145709000376","journal-title":"Int J Neuropsychopharmacol"},{"key":"6216_CR103","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1523\/jneurosci.22-08-03262.2002","volume":"22","author":"A Conti","year":"2002","unstructured":"Conti A, Cryan J, Dalvi A, Lucki I, Blendy J (2002) CAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs. J Neurosci 22:3262\u20133268. https:\/\/doi.org\/10.1523\/jneurosci.22-08-03262.2002","journal-title":"J Neurosci"},{"key":"6216_CR104","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1523\/jneurosci.16-07-02365.1996","volume":"16","author":"M Nibuya","year":"1996","unstructured":"Nibuya M, Nestler E, Duman R (1996) Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci Off J Soc Neurosci 16:2365\u20132372. https:\/\/doi.org\/10.1523\/jneurosci.16-07-02365.1996","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"6216_CR105","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/s0896-6273(00)81010-7","volume":"20","author":"X Tao","year":"1998","unstructured":"Tao X, Finkbeiner S, Arnold D, Shaywitz A, Greenberg M (1998) Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 20:709\u2013726. https:\/\/doi.org\/10.1016\/s0896-6273(00)81010-7","journal-title":"Neuron"},{"issue":"3","key":"6216_CR106","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1017\/s1461145709990630","volume":"13","author":"C Mombereau","year":"2010","unstructured":"Mombereau C, Gur T, Onksen J, Blendy J (2010) Differential effects of acute and repeated citalopram in mouse models of anxiety and depression. Int J Neuropsychopharmacol 13(3):321\u2013334. https:\/\/doi.org\/10.1017\/s1461145709990630","journal-title":"Int J Neuropsychopharmacol"},{"key":"6216_CR107","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.2174\/1570159x22666240206111838","volume":"22","author":"W Guan","year":"2024","unstructured":"Guan W, Ni M, Gu H, Yang Y (2024) CREB: a promising therapeutic target for treating psychiatric disorders. Curr Neuropharmacol 22:2384\u20132401. https:\/\/doi.org\/10.2174\/1570159x22666240206111838","journal-title":"Curr Neuropharmacol"},{"key":"6216_CR108","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s12035-011-8209-x","volume":"44","author":"A Barco","year":"2011","unstructured":"Barco A, Marie H (2011) Genetic approaches to investigate the role of CREB in neuronal plasticity and memory. Mol Neurobiol 44:330\u2013349. https:\/\/doi.org\/10.1007\/s12035-011-8209-x","journal-title":"Mol Neurobiol"},{"key":"6216_CR109","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nrn1346","volume":"5","author":"G Thomas","year":"2004","unstructured":"Thomas G, Huganir R (2004) MAPK cascade signalling and synaptic plasticity. Nat Rev Neurosci 5:173\u2013183. https:\/\/doi.org\/10.1038\/nrn1346","journal-title":"Nat Rev Neurosci"},{"key":"6216_CR110","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2001.00054.x","author":"J Sweatt","year":"2001","unstructured":"Sweatt J (2001) The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J Neurochem. https:\/\/doi.org\/10.1046\/j.1471-4159.2001.00054.x","journal-title":"J Neurochem"},{"key":"6216_CR111","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.conb.2004.04.001","volume":"14","author":"J Sweatt","year":"2004","unstructured":"Sweatt J (2004) Mitogen-activated protein kinases in synaptic plasticity and memory. Curr Opin Neurobiol 14:311\u2013317. https:\/\/doi.org\/10.1016\/j.conb.2004.04.001","journal-title":"Curr Opin Neurobiol"},{"key":"6216_CR112","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/mp.2016.232","volume":"23","author":"M Ullrich","year":"2017","unstructured":"Ullrich M, Weber M, Post A, Post A, Popp S, Grein J, Zechner M, Gonz\u00e1lez H et al (2017) OCD-like behavior is caused by dysfunction of thalamo-amygdala circuits and upregulated TrkB\/ERK-MAPK signaling as a result of SPRED2 deficiency. Mol Psychiatry 23:444\u2013458. https:\/\/doi.org\/10.1038\/mp.2016.232","journal-title":"Mol Psychiatry"},{"key":"6216_CR113","doi-asserted-by":"publisher","first-page":"6197","DOI":"10.1007\/s12035-019-1524-3","volume":"56","author":"J Wang","year":"2019","unstructured":"Wang J, Mao L (2019) The ERK pathway: molecular mechanisms and treatment of depression. Mol Neurobiol 56:6197\u20136205. https:\/\/doi.org\/10.1007\/s12035-019-1524-3","journal-title":"Mol Neurobiol"},{"key":"6216_CR114","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2006.04859.x","author":"J Horwood","year":"2006","unstructured":"Horwood J, Dufour F, Laroche S, Davis S (2006) Signalling mechanisms mediated by the phosphoinositide 3\u2010kinase\/Akt cascade in synaptic plasticity and memory in the rat. Eur J Neurosci. https:\/\/doi.org\/10.1111\/j.1460-9568.2006.04859.x","journal-title":"Eur J Neurosci"},{"issue":"10","key":"6216_CR115","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1101\/lm.1067808","volume":"15","author":"L Sui","year":"2008","unstructured":"Sui L, Wang J, Li B (2008) Role of the phosphoinositide 3-kinase-Akt-mammalian target of the rapamycin signaling pathway in long-term potentiation and trace fear conditioning memory in rat medial prefrontal cortex. Learn Mem 15(10):762\u2013776. https:\/\/doi.org\/10.1101\/lm.1067808","journal-title":"Learn Mem"},{"key":"6216_CR116","doi-asserted-by":"publisher","first-page":"11300","DOI":"10.1523\/jneurosci.2270-05.2005","volume":"25","author":"J Jaworski","year":"2005","unstructured":"Jaworski J, Spangler S, Seeburg D, Hoogenraad C, Sheng M (2005) Control of dendritic arborization by the phosphoinositide-3\u2032-kinase\u2013Akt\u2013mammalian target of rapamycin pathway. J Neurosci 25:11300\u201311312. https:\/\/doi.org\/10.1523\/jneurosci.2270-05.2005","journal-title":"J Neurosci"},{"key":"6216_CR117","doi-asserted-by":"publisher","first-page":"6352","DOI":"10.1523\/jneurosci.0995-04.2004","volume":"24","author":"L Hou","year":"2004","unstructured":"Hou L, Klann E (2004) Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression. J Neurosci 24:6352\u20136361. https:\/\/doi.org\/10.1523\/jneurosci.0995-04.2004","journal-title":"J Neurosci"},{"issue":"5","key":"6216_CR118","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1111\/bcp.12845","volume":"82","author":"Z Ign\u00e1cio","year":"2016","unstructured":"Ign\u00e1cio Z, R\u00e9us G, Arent C, Abelaira H, Pitcher M, Quevedo J (2016) New perspectives on the involvement of mTOR in depression as well as in the action of antidepressant drugs. Br J Clin Pharmacol 82(5):1280\u20131290. https:\/\/doi.org\/10.1111\/bcp.12845","journal-title":"Br J Clin Pharmacol"},{"key":"6216_CR119","doi-asserted-by":"publisher","unstructured":"Chen Y, Guan W, Wang M, Lin X (2024) PI3K-AKT\/mTOR signaling in psychiatric disorders: a valuable target to stimulate or suppress?. Int J Neuropsychopharmacology 27. https:\/\/doi.org\/10.1093\/ijnp\/pyae010","DOI":"10.1093\/ijnp\/pyae010"},{"key":"6216_CR120","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.801234","author":"Y Luo","year":"2021","unstructured":"Luo Y, Ye X, Fang Y, Li M, Xia Z, Liu J, Lin X, Huang Z et al (2021) MTORC1 signaling pathway mediates chronic stress-induced synapse loss in the hippocampus. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2021.801234","journal-title":"Front Pharmacol"},{"key":"6216_CR121","doi-asserted-by":"publisher","unstructured":"Naze S, Hearne L, Sanz-Leon P, Robinson C, Hall C, Sonkusare S, Burgher B, Zalesky A, Roberts J et al (2025) Mechanisms and interventions promoting healthy frontostriatal dynamics in obsessive-compulsive disorder. Nat Communications 16. https:\/\/doi.org\/10.1038\/s41467-025-62190-2","DOI":"10.1038\/s41467-025-62190-2"},{"issue":"9","key":"6216_CR122","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/j.celrep.2017.05.023","volume":"19","author":"M Bijata","year":"2017","unstructured":"Bijata M, Labus J, Guseva D, Stawarski M, Butzlaff M, Dzwonek J, Schneeberg J, B\u00f6hm K et al (2017) Synaptic remodeling depends on signaling between serotonin receptors and the extracellular matrix. Cell Rep 19(9):1767\u20131782. https:\/\/doi.org\/10.1016\/j.celrep.2017.05.023","journal-title":"Cell Rep"},{"key":"6216_CR123","doi-asserted-by":"publisher","unstructured":"Speranza L, Labus J, Volpicelli F, Guseva D, Lacivita E, Leopoldo M, Bellenchi G, Porzio U et al (2017) Serotonin 5\u2010HT7 receptor increases the density of dendritic spines and facilitates synaptogenesis in forebrain neurons. J Neurochemistry 141. https:\/\/doi.org\/10.1111\/jnc.13962","DOI":"10.1111\/jnc.13962"},{"key":"6216_CR124","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pneurobio.2016.03.007","volume":"151","author":"A Wirth","year":"2017","unstructured":"Wirth A, Holst K, Ponimaskin E (2017) How serotonin receptors regulate morphogenic signalling in neurons. Prog Neurobiol 151:35\u201356. https:\/\/doi.org\/10.1016\/j.pneurobio.2016.03.007","journal-title":"Prog Neurobiol"},{"key":"6216_CR125","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1001\/jamapsychiatry.2017.1567","volume":"74","author":"S Attwells","year":"2017","unstructured":"Attwells S, Setiawan E, Wilson A, Rusjan P, Mizrahi R, Miler L, Xu C, Richter M et al (2017) Inflammation in the neurocircuitry of obsessive-compulsive disorder. JAMA Psychiat 74:833\u2013840. https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.1567","journal-title":"JAMA Psychiat"},{"key":"6216_CR126","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11920-019-1062-8","volume":"21","author":"M Gerentes","year":"2019","unstructured":"Gerentes M, Pelissolo A, Rajagopal K, Tamouza R, Hamdani N (2019) Obsessive-compulsive disorder: autoimmunity and neuroinflammation. Curr Psychiatry Rep 21:1\u201310. https:\/\/doi.org\/10.1007\/s11920-019-1062-8","journal-title":"Curr Psychiatry Rep"},{"key":"6216_CR127","doi-asserted-by":"publisher","unstructured":"Sarmin N, Roknuzzaman A, Sarker R, Rashid M, Hasan A, Qusar M, Kabir E, Islam M et al (2024) Exploring the role of interleukin-1\u03b2 and interleukin-6 in the pathophysiology of obsessive-compulsive disorder. PLOS ONE 19. https:\/\/doi.org\/10.1371\/journal.pone.0306125","DOI":"10.1371\/journal.pone.0306125"},{"key":"6216_CR128","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.bbi.2025.01.013","volume":"126","author":"G Chen","year":"2025","unstructured":"Chen G, Zhao X, Xie M, Chen H, Shao C, Zhang X, Wu Y, Liu N et al (2025) Serum metabolites and inflammation predict brain functional connectivity changes in obsessive-compulsive disorder. Brain Behav Immun 126:113\u2013125. https:\/\/doi.org\/10.1016\/j.bbi.2025.01.013","journal-title":"Brain Behav Immun"},{"key":"6216_CR129","doi-asserted-by":"publisher","unstructured":"Rodr\u00edguez N, Morer A, Gonz\u00e1lez-Navarro E, Serra-Pages C, Boloc D, Torres T, Garc\u00eda-Cerro S, Mas S et al (2017) Inflammatory dysregulation of monocytes in pediatric patients with obsessive-compulsive disorder. J Neuroinflammation 14. https:\/\/doi.org\/10.1186\/s12974-017-1042-z","DOI":"10.1186\/s12974-017-1042-z"},{"key":"6216_CR130","doi-asserted-by":"publisher","first-page":"705","DOI":"10.4103\/1673-5374.322423","volume":"17","author":"J Cornell","year":"2021","unstructured":"Cornell J, Salinas S, Huang H, Zhou M (2021) Microglia regulation of synaptic plasticity and learning and memory. Neural Regen Res 17:705\u2013716. https:\/\/doi.org\/10.4103\/1673-5374.322423","journal-title":"Neural Regen Res"},{"issue":"10","key":"6216_CR131","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.it.2015.08.008","volume":"36","author":"Y Wu","year":"2015","unstructured":"Wu Y, Dissing-Olesen L, MacVicar B, Stevens B (2015) Microglia: dynamic mediators of synapse development and plasticity. Trends Immunol 36(10):605\u2013613. https:\/\/doi.org\/10.1016\/j.it.2015.08.008","journal-title":"Trends Immunol"},{"key":"6216_CR132","doi-asserted-by":"publisher","DOI":"10.3390\/cells10030686","author":"M Geloso","year":"2021","unstructured":"Geloso M, D\u2019Ambrosi N (2021) Microglial pruning: relevance for synaptic dysfunction in multiple sclerosis and related experimental models. Cells. https:\/\/doi.org\/10.3390\/cells10030686","journal-title":"Cells"},{"key":"6216_CR133","doi-asserted-by":"publisher","DOI":"10.3389\/fnsyn.2017.00009","author":"R Paolicelli","year":"2017","unstructured":"Paolicelli R, Ferretti M (2017) Function and dysfunction of microglia during brain development: consequences for synapses and neural circuits. Front Synaptic Neurosci. https:\/\/doi.org\/10.3389\/fnsyn.2017.00009","journal-title":"Front Synaptic Neurosci"},{"key":"6216_CR134","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8606057","author":"L Frick","year":"2016","unstructured":"Frick L, Pittenger C (2016) Microglial dysregulation in OCD, Tourette syndrome, and PANDAS. J Immunol Res. https:\/\/doi.org\/10.1155\/2016\/8606057","journal-title":"J Immunol Res"},{"key":"6216_CR135","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1038\/sj.npp.1301029","volume":"31","author":"C Zhu","year":"2006","unstructured":"Zhu C, Blakely R, Hewlett W (2006) The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 31:2121\u20132131. https:\/\/doi.org\/10.1038\/sj.npp.1301029","journal-title":"Neuropsychopharmacology"},{"key":"6216_CR136","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/s0197-0186(98)00026-6","volume":"33","author":"R M\u00f6ssner","year":"1998","unstructured":"M\u00f6ssner R, Heils A, St\u00f6ber G, Okladnova O, Daniel S, Lesch K (1998) Enhancement of serotonin transporter function by tumor necrosis factor alpha but not by interleukin-6. Neurochem Int 33:251\u2013254. https:\/\/doi.org\/10.1016\/s0197-0186(98)00026-6","journal-title":"Neurochem Int"},{"key":"6216_CR137","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1089\/cap.2015.0147","volume":"26","author":"M Amitai","year":"2016","unstructured":"Amitai M, Taler M, Carmel M, Michaelovsky E, Eilat T, Yablonski M, Orpaz N, Chen A et al (2016) The relationship between plasma cytokine levels and response to selective serotonin reuptake inhibitor treatment in children and adolescents with depression and\/or anxiety disorders. J Child Adolesc Psychopharmacol 26:727\u2013732. https:\/\/doi.org\/10.1089\/cap.2015.0147","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"6216_CR138","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.psyneuen.2018.05.026","volume":"95","author":"E Haroon","year":"2018","unstructured":"Haroon E, Daguanno A, Woolwine B, Goldsmith D, Baer W, Wommack E, Felger J, Miller A (2018) Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder. Psychoneuroendocrinology 95:43\u201349. https:\/\/doi.org\/10.1016\/j.psyneuen.2018.05.026","journal-title":"Psychoneuroendocrinology"},{"key":"6216_CR139","doi-asserted-by":"publisher","unstructured":"Arteaga-Henr\u00edquez G, Simon M, Burger B, Weidinger E, Wijkhuijs A, Arolt V, Birkenhager T, Musil R et al (2019) Low-grade inflammation as a predictor of antidepressant and anti-inflammatory therapy response in MDD patients: a systematic review of the literature in combination with an analysis of experimental data collected in the EU-MOODINFLAME consortium. Front Psychiatry 10. https:\/\/doi.org\/10.3389\/fpsyt.2019.00458","DOI":"10.3389\/fpsyt.2019.00458"},{"key":"6216_CR140","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10787-020-00777-5","volume":"29","author":"V Dionisie","year":"2020","unstructured":"Dionisie V, Filip G, Manea M, Manea M, Riga S (2020) The anti-inflammatory role of SSRI and SNRI in the treatment of depression: a review of human and rodent research studies. Inflammopharmacology 29:75\u201390. https:\/\/doi.org\/10.1007\/s10787-020-00777-5","journal-title":"Inflammopharmacology"},{"key":"6216_CR141","doi-asserted-by":"publisher","DOI":"10.3390\/ph18060867","author":"L Bleibel","year":"2025","unstructured":"Bleibel L, Soko\u0142owska P, Henrykowska G, Owczarek J, Wiktorowska-Owczarek A (2025) Unveiling the anti-inflammatory effects of antidepressants: a systematic review of human studies over the last decade. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph18060867","journal-title":"Pharmaceuticals (Basel)"},{"key":"6216_CR142","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.pnpbp.2017.03.016","volume":"80","author":"P Ga\u0142ecki","year":"2018","unstructured":"Ga\u0142ecki P, Mossakowska-W\u00f3jcik J, Talarowska M (2018) The anti-inflammatory mechanism of antidepressants \u2013 SSRIs, SNRIs. Prog Neuropsychopharmacol Biol Psychiatry 80:291\u2013294. https:\/\/doi.org\/10.1016\/j.pnpbp.2017.03.016","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"6216_CR143","doi-asserted-by":"publisher","DOI":"10.2174\/1570180817999200520122910","author":"H Ghasemi","year":"2020","unstructured":"Ghasemi H, Nomani H, Sahebkar A, Mohammadpour A (2020) Anti-inflammatory augmentation therapy in obsessive-compulsive disorder: a review. Lett Drug Des Discovery. https:\/\/doi.org\/10.2174\/1570180817999200520122910","journal-title":"Lett Drug Des Discovery"},{"key":"6216_CR144","doi-asserted-by":"publisher","first-page":"695","DOI":"10.2147\/jep.s255375","volume":"12","author":"G Grassi","year":"2021","unstructured":"Grassi G, Cecchelli C, Vignozzi L, Pacini S (2021) Investigational and experimental drugs to treat obsessive-compulsive disorder. J Exp Pharmacol 12:695\u2013706. https:\/\/doi.org\/10.2147\/jep.s255375","journal-title":"J Exp Pharmacol"},{"key":"6216_CR145","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s11011-023-01314-3","volume":"39","author":"S Bhatt","year":"2023","unstructured":"Bhatt S, Anitha K, Chellappan D, Mukherjee D, Shilpi S, Suttee A, Gupta G, Singh T et al (2023) Targeting inflammatory signaling in obsessive compulsive disorder: a promising approach. Metab Brain Dis 39:335\u2013346. https:\/\/doi.org\/10.1007\/s11011-023-01314-3","journal-title":"Metab Brain Dis"},{"issue":"Suppl 1","key":"6216_CR146","doi-asserted-by":"publisher","first-page":"S295","DOI":"10.1192\/j.eurpsy.2022.753","volume":"65","author":"M Constable","year":"2022","unstructured":"Constable M, Hou R (2022) Inflammatory markers in obsessive-compulsive disorder: a systematic review and meta-analysis. Eur Psychiatry 65(Suppl 1):S295. https:\/\/doi.org\/10.1192\/j.eurpsy.2022.753","journal-title":"Eur Psychiatry"},{"issue":"Suppl 1","key":"6216_CR147","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1192\/j.eurpsy.2024.142","volume":"67","author":"Y Chen","year":"2024","unstructured":"Chen Y, Li Q, Wang Y, Wang Y, Long F, Li F (2024) A multivariate meta-analysis of peripheral cytokine levels in obsessive compulsive disorder. Eur Psychiatry 67(Suppl 1):S42\u2013S43. https:\/\/doi.org\/10.1192\/j.eurpsy.2024.142","journal-title":"Eur Psychiatry"},{"key":"6216_CR148","doi-asserted-by":"publisher","DOI":"10.1111\/acps.13026","author":"A Maia","year":"2019","unstructured":"Maia A, Oliveira J, Lajnef M, Mallet L, Tamouza R, Leboyer M, Oliveira-Maia A (2019) Oxidative and nitrosative stress markers in obsessive\u2013compulsive disorder: a systematic review and meta\u2010analysis. Acta Psychiatr Scand. https:\/\/doi.org\/10.1111\/acps.13026","journal-title":"Acta Psychiatr Scand"},{"key":"6216_CR149","doi-asserted-by":"publisher","unstructured":"Mohammadi A, Balandeh E, and Milajerdi A (2021) Malondialdehyde concentrations in obsessive\u2013compulsive disorder: a systematic review and meta-analysis. Annals of General Psychiatry, p 20. https:\/\/doi.org\/10.1186\/s12991-021-00354-2","DOI":"10.1186\/s12991-021-00354-2"},{"key":"6216_CR150","doi-asserted-by":"publisher","DOI":"10.4103\/jmhhb.jmhhb_130_25","author":"D Kaur","year":"2026","unstructured":"Kaur D, Sidana AK, Mehta S, Gupta S (2026) Comparison of fluvoxamine and fluoxetine on clinical and inflammatory markers in patients with obsessive-compulsive disorder: a 12-week randomised study. J Ment Health Hum Behav. https:\/\/doi.org\/10.4103\/jmhhb.jmhhb_130_25","journal-title":"J Ment Health Hum Behav"},{"issue":"41","key":"6216_CR151","doi-asserted-by":"publisher","first-page":"5647","DOI":"10.2174\/0929867325666171222163645","volume":"25","author":"U Albert","year":"2019","unstructured":"Albert U, Marazziti D, Di Salvo G, Solia F, Rosso G, Maina G (2019) A systematic review of evidence-based treatment strategies for obsessive- compulsive disorder resistant to first-line pharmacotherapy. Curr Med Chem 25(41):5647\u20135661. https:\/\/doi.org\/10.2174\/0929867325666171222163645","journal-title":"Curr Med Chem"},{"key":"6216_CR152","doi-asserted-by":"publisher","unstructured":"Conti D, Girone N, Boscacci M, Casati L, Cassina N, Cerolini, L, Giacovelli L, Vigan\u00f2 C et al (2024) The use of antipsychotics in obsessive compulsive disorder. Human Psychopharmacology: Clin Experimental 39. https:\/\/doi.org\/10.1002\/hup.2893","DOI":"10.1002\/hup.2893"},{"key":"6216_CR153","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.euroneuro.2006.07.002","volume":"17","author":"P Skapinakis","year":"2007","unstructured":"Skapinakis P, Papatheodorou T, Mavreas V (2007) Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive\u2013compulsive disorder: a meta-analysis of the randomized controlled trials. Eur Neuropsychopharmacol 17:79\u201393. https:\/\/doi.org\/10.1016\/j.euroneuro.2006.07.002","journal-title":"Eur Neuropsychopharmacol"},{"key":"6216_CR154","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/sj.mp.4001823","volume":"11","author":"M Bloch","year":"2006","unstructured":"Bloch M, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken M, Leckman J (2006) A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry 11:622\u2013632. https:\/\/doi.org\/10.1038\/sj.mp.4001823","journal-title":"Mol Psychiatry"},{"key":"6216_CR155","doi-asserted-by":"publisher","DOI":"10.3390\/biom10081134","author":"T Kikuchi","year":"2020","unstructured":"Kikuchi T (2020) Is memantine effective as an NMDA receptor antagonist in adjunctive therapy for schizophrenia? Biomolecules. https:\/\/doi.org\/10.3390\/biom10081134","journal-title":"Biomolecules"},{"key":"6216_CR156","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3233\/jad-170672","volume":"62","author":"J Folch","year":"2017","unstructured":"Folch J, Busquets O, Ettcheto M, S\u00e1nchez-L\u00f3pez E, Castro-Torres R, Verdaguer E, Garc\u00eda M, Olloquequi J et al (2017) Memantine for the treatment of dementia: a review on its current and future applications. J Alzheimers Dis 62:1223\u20131240. https:\/\/doi.org\/10.3233\/jad-170672","journal-title":"J Alzheimers Dis"},{"key":"6216_CR157","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.neuropharm.2018.09.021","volume":"143","author":"V Lazarevic","year":"2018","unstructured":"Lazarevic V, Yang Y, Ivanova D, Fejtov\u00e1 A, Svenningsson P (2018) Riluzole attenuates the efficacy of glutamatergic transmission by interfering with the size of the readily releasable neurotransmitter pool. Neuropharmacology 143:38\u201348. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.09.021","journal-title":"Neuropharmacology"},{"key":"6216_CR158","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.2174\/1570159x19666201230144109","volume":"19","author":"G Raghu","year":"2020","unstructured":"Raghu G, Berk M, Campochiaro P, Jaeschke H, Marenzi G, Richeldi L, Wen F, Nicoletti F et al (2020) The multifaceted therapeutic role of N-acetylcysteine (NAC) in disorders characterized by oxidative stress. Curr Neuropharmacol 19:1202\u20131224. https:\/\/doi.org\/10.2174\/1570159x19666201230144109","journal-title":"Curr Neuropharmacol"},{"key":"6216_CR159","doi-asserted-by":"publisher","unstructured":"Durieux A, Fernandes C, Murphy D, Labouesse, M, Giovanoli, S, Meyer U, Li Q, So P et al (2015) Targeting glia with N-acetylcysteine modulates brain glutamate and behaviors relevant to neurodevelopmental disorders in C57BL\/6J mice. Front Behavioral Neurosci 9. https:\/\/doi.org\/10.3389\/fnbeh.2015.00343","DOI":"10.3389\/fnbeh.2015.00343"},{"key":"6216_CR160","doi-asserted-by":"publisher","unstructured":"Olive F, Powell G, McClure E, and Gipson C (2018) Neurotransmitter systems: glutamate. The Therapeutic Use of N-Acetylcysteine (NAC) in Medicine. https:\/\/doi.org\/10.1007\/978-981-10-5311-5_2","DOI":"10.1007\/978-981-10-5311-5_2"},{"key":"6216_CR161","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.pnpbp.2018.12.009","volume":"90","author":"D Zhou","year":"2019","unstructured":"Zhou D, Zhou X, Li Y, Zhang K, Lv Z, Chen X, Wan L, Wang W et al (2019) Augmentation agents to serotonin reuptake inhibitors for treatment-resistant obsessive-compulsive disorder: a network meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 90:277\u2013287. https:\/\/doi.org\/10.1016\/j.pnpbp.2018.12.009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"6216_CR162","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1124\/molpharm.122.000563","volume":"103","author":"S Srinivasan","year":"2022","unstructured":"Srinivasan S (2022) Targeting circuit abnormalities in neurodegenerative disease. Mol Pharmacol 103:38\u201344. https:\/\/doi.org\/10.1124\/molpharm.122.000563","journal-title":"Mol Pharmacol"},{"key":"6216_CR163","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-genet-072820-023642","author":"D Exposito-Alonso","year":"2022","unstructured":"Exposito-Alonso D, Rico B (2022) Mechanisms underlying circuit dysfunction in neurodevelopmental disorders. Annu Rev Genet. https:\/\/doi.org\/10.1146\/annurev-genet-072820-023642","journal-title":"Annu Rev Genet"},{"key":"6216_CR164","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s40501-016-0087-4","volume":"3","author":"M Fullana","year":"2016","unstructured":"Fullana M, Simpson H (2016) The potential use of neuroimaging biomarkers in the treatment of obsessive-compulsive disorder. Curr Treat Options Psychiatry 3:246\u2013252. https:\/\/doi.org\/10.1007\/s40501-016-0087-4","journal-title":"Curr Treat Options Psychiatry"},{"key":"6216_CR165","doi-asserted-by":"publisher","unstructured":"Shephard E, Stern E, Van Den Heuvel O, Costa D, Batistuzzo M, Godoy P, Lopes A, Brunoni A et al (2021) Toward a neurocircuit-based taxonomy to guide treatment of obsessive\u2013compulsive disorder. Mol Psychiatry, pp 1\u201322. https:\/\/doi.org\/10.1038\/s41380-020-01007-8","DOI":"10.1038\/s41380-020-01007-8"},{"key":"6216_CR166","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41591-022-02197-0","volume":"29","author":"K Scangos","year":"2023","unstructured":"Scangos K, State M, Miller A, Baker J, Williams L (2023) New and emerging approaches to treat psychiatric disorders. Nat Med 29:317\u2013333. https:\/\/doi.org\/10.1038\/s41591-022-02197-0","journal-title":"Nat Med"},{"issue":"5","key":"6216_CR167","doi-asserted-by":"publisher","first-page":"e605","DOI":"10.4088\/jcp.14r09758","volume":"77","author":"Y Issari","year":"2016","unstructured":"Issari Y, Jakubovski E, Bartley C, Pittenger C, Bloch M (2016) Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis. J Clin Psychiatry 77(5):e605\u2013e611. https:\/\/doi.org\/10.4088\/jcp.14r09758","journal-title":"J Clin Psychiatry"},{"key":"6216_CR168","doi-asserted-by":"publisher","unstructured":"Li Y, Zhang C, Weidacker K, Zhang Y, He N, Jin H, Chen W, Voon V et al (2019) Investigation of anterior cingulate cortex gamma-aminobutyric acid and glutamate-glutamine levels in obsessive-compulsive disorder using magnetic resonance spectroscopy. BMC Psychiatry 19. https:\/\/doi.org\/10.1186\/s12888-019-2160-1","DOI":"10.1186\/s12888-019-2160-1"},{"key":"6216_CR169","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1007\/s44411-025-00255-w","volume":"126","author":"A Fedai","year":"2025","unstructured":"Fedai A, \u00c7etin B (2025) New inflammation markers in patients with obsessive\u2013compulsive disorder. Bratisl Lek Listy 126:2680\u20132687. https:\/\/doi.org\/10.1007\/s44411-025-00255-w","journal-title":"Bratisl Lek Listy"},{"key":"6216_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2025.119457","author":"H Wang","year":"2025","unstructured":"Wang H, Teng C, Zhang D, Zhang W, Zhang H, Wu X, Hu X, Guan C (2025) Abnormal intrinsic brain activity of the sensory-motor area as a predictor of the response to selective serotonin reuptake inhibitors in treatment-na\u00efve obsessive-compulsive disorder. J Affect Disord. https:\/\/doi.org\/10.1016\/j.jad.2025.119457","journal-title":"J Affect Disord"},{"key":"6216_CR171","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.4103\/psychiatry.indianjpsychiatry_520_18","volume":"61","author":"K Sheshachala","year":"2019","unstructured":"Sheshachala K, Narayanaswamy J (2019) Glutamatergic augmentation strategies in obsessive\u2013compulsive disorder. Indian J Psychiatry 61:S58\u2013S65. https:\/\/doi.org\/10.4103\/psychiatry.indianjpsychiatry_520_18","journal-title":"Indian J Psychiatry"},{"key":"6216_CR172","doi-asserted-by":"publisher","unstructured":"Chen Y, Wang P, Li Z (2025) Exploring genetic and epigenetic markers for predicting or monitoring response to cognitive-behavioral therapy in obsessive-compulsive disorder: a systematic review. Neurosci Biobehav Rev 174. https:\/\/doi.org\/10.1016\/j.neubiorev.2025.106192","DOI":"10.1016\/j.neubiorev.2025.106192"},{"key":"6216_CR173","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/acps.13809","volume":"152","author":"P Tseng","year":"2025","unstructured":"Tseng P, Hsu C, Hung C, Liang C, Wang H, Stubbs B, Carvalho A, Brunoni A et al (2025) The efficacy and acceptability of non-invasive brain stimulation interventions for obsessive-compulsive disorder management: a network meta-analysis based on 24 stimulation methods. Acta Psychiatr Scand 152:112\u2013124. https:\/\/doi.org\/10.1111\/acps.13809","journal-title":"Acta Psychiatr Scand"},{"key":"6216_CR174","doi-asserted-by":"publisher","first-page":"ii171","DOI":"10.1093\/ijnp\/pyaf052.342","volume":"28","author":"J Narayanaswamy","year":"2025","unstructured":"Narayanaswamy J (2025) 593. Evaluating OCD circuits with non-invasive neuromodulation: investigative and therapeutic studies. Int J Neuropsychopharmacol 28:ii171\u2013ii172. https:\/\/doi.org\/10.1093\/ijnp\/pyaf052.342","journal-title":"Int J Neuropsychopharmacol"},{"key":"6216_CR175","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1080\/14737175.2016.1199960","volume":"16","author":"N Hazari","year":"2016","unstructured":"Hazari N, Narayanaswamy J, Arumugham S (2016) Predictors of response to serotonin reuptake inhibitors in obsessive-compulsive disorder. Expert Rev Neurother 16:1175\u20131191. https:\/\/doi.org\/10.1080\/14737175.2016.1199960","journal-title":"Expert Rev Neurother"},{"key":"6216_CR176","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg4775","author":"D Krainc","year":"2023","unstructured":"Krainc D, Martin W, Casey B, Jensen F, Tishkoff S, Potter W, Hyman S (2023) Shifting the trajectory of therapeutic development for neurological and psychiatric disorders. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.adg4775","journal-title":"Sci Transl Med"},{"key":"6216_CR177","doi-asserted-by":"publisher","first-page":"7384","DOI":"10.1002\/alz.14063","volume":"20","author":"S Arnold","year":"2024","unstructured":"Arnold S, Hyman B, Betensky R, Dodge H (2024) Pathways to personalized medicine\u2014embracing heterogeneity for progress in clinical therapeutics research in Alzheimer\u2019s disease. Alzheimers Dement 20:7384\u20137394. https:\/\/doi.org\/10.1002\/alz.14063","journal-title":"Alzheimers Dement"},{"key":"6216_CR178","doi-asserted-by":"publisher","first-page":"E59","DOI":"10.1503\/jpn.230090","volume":"49","author":"M Sohn","year":"2024","unstructured":"Sohn M, Brown J, Sharma P, Ziemann U, McGirr A (2024) Pharmacological adjuncts and transcranial magnetic stimulation-induced synaptic plasticity: a systematic review. J Psychiatry Neurosci\u202f: JPN 49:E59\u2013E76. https:\/\/doi.org\/10.1503\/jpn.230090","journal-title":"J Psychiatry Neurosci : JPN"},{"key":"6216_CR179","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12112506","author":"M Sharbafshaaer","year":"2024","unstructured":"Sharbafshaaer M, Cirillo G, Esposito F, Tedeschi G, Trojsi F (2024) Harnessing brain plasticity: the therapeutic power of repetitive transcranial magnetic stimulation (rTMS) and theta burst stimulation (TBS) in neurotransmitter modulation, receptor dynamics, and neuroimaging for neurological innovations. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines12112506","journal-title":"Biomedicines"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06216-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06216-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06216-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:02:03Z","timestamp":1789736523000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06216-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":179,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6216"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06216-w","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"30 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was not required for this study, as it is a narrative review based exclusively on previously published literature and does not involve human participants or animal experimentation.","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AI-assisted tools were used solely for language refinement and to improve the clarity of figure presentation. All scientific content, interpretation, and final editing were performed and verified by the author, who takes full responsibility for the accuracy and integrity of the manuscript.","order":3,"name":"Ethics","label":"Declaration of Artificial Intelligence Use","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"905"}}